The global ovarian cancer diagnostic market is expanding rapidly, fueled by the rising incidence of ovarian cancer, heightened awareness about early detection, and the development of novel diagnostic tools. According to recent industry reports, the market is projected to continue its upward trajectory, bolstered by technological advancements and an increasing focus on personalized medicine.
Global Ovarian Cancer Diagnostic Market size was valued at USD 1.57 billion in 2022 and is poised to grow from USD 1.77 billion in 2023 to USD 9.67 billion by 2031, growing at a CAGR of 23.7% in the forecast period (2024-2031).
Like
Comment
Share
